NUH 0.00% 8.1¢ nuheara limited

Ann: NUH Expands Health Research in Auditory Processing Disorders, page-80

  1. 2,618 Posts.
    lightbulb Created with Sketch. 634
    The interesting thing in all this is that APD is not even regarded as a potential revenue pot for NUH - they are doing this research as part of their overall ethos and the CEO's passion for hearing health (he has total hearing loss in one ear). NUH's big money will come from Boost (mild to moderate hearing loss) and LiveIQ (consumer audio) - this APD research project is not a play to capture a new market for revenue purposes. If the research is successful and NUH sells a few more units to people with APD, then so be it - NUH is not pinning any hopes or throwing marketing spend on this sector.

    Yet somehow Bruutz is fearful of NUH being successful, given he appears to be heavily invested in a one product company who are trialing a very large headworn device aimed at assisting autism sufferers. It's clear that's his sole motivation once you read his other posts, even though NUH aren't even playing in the same patch as his stock. Something's not right when someone is posting around the clock. There's emotionally invested (I probably fall into that category) and then there's something else altogether.
 
watchlist Created with Sketch. Add NUH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.